摘要
猪带绦虫 45W 基因家族是由一群结构和功能相似的基因组成的。45W 基因在反式
剪接作用下产生 A、B 和 C 三型转录本,其中 A 型转录本是由外显子Ⅰ、Ⅱ、Ⅲ和Ⅳ
组成;B 型转录本由Ⅰ、Ⅲ和Ⅳ组成;C 型转录本由Ⅰ和Ⅳ组成,在不同的转录本中
的同一外显子有高度的同源性,也存在变异。
45W 基因已被认为是预防猪囊尾蚴病的基因工程疫苗侯选基因之一。本试验成功
地从六钩蚴中克隆到 4B 基因。通过对 4B 基因序列的比较,发现 4B 基因是 45W 基因
中较为特殊的一个基因,该基因与 45W 其他相关基因之间变异范围为 17.8%-20.6%,
但该基因在不同虫株间和不同克隆间高度保守。为了研究 4B 蛋白的结构和功能,并
为研制和开发有效的猪带绦虫基因工程疫苗打下基础,本研究将 4B 基因及其 3′-
端的剪切片段克隆到 pET-28a 载体中,并在大肠杆菌 BL21 中成功地表达,与预期分
子大小一致,为 18 kDa,经 Western blot 检测,表达的重组蛋白能被猪囊尾蚴病人
血清识别,为开发高效猪囊尾蚴基因工程疫苗打下了基础。
45W 基因的这独特的交替剪接形式引起了寄生虫学家们的广泛兴趣。为了研究
4B 蛋白在猪囊尾蚴组织中的结构和功能,试验中利用大肠杆菌表达系统表达的 4B 重
组蛋白,分子量约为 18 kDa,腹腔注射免疫小白鼠,经两次免疫后,采血,并用该
血清与猪囊尾蚴组织匀浆蛋白做免疫印迹,发现在 50 kDa 处有一明显的印迹条带,
而 18 kDa 处没有。表明在猪囊尾蚴组织蛋白中 45W 蛋白各型蛋白可能以同型或异型
寡聚体形式存在。用计算机软件分析发现 4B 蛋白的抗原性很好,用蛋白质结构数据
库 (Protein Data Base, PDB)比较,发现 4B 蛋白(包括 45W 其他型)存在纤连蛋
白(Fibronectin, FN)结构域。45W 蛋白寡聚体形式组成与纤链蛋白的组织构成十
分相似,推测 45W 蛋白与猪囊尾蚴囊壁的形成有关。
家蚕表达系统通过将外源目的基因插入家蚕核多角体病毒(BmNPV)多角体启动
子(polyhedrin promoter)的下游,外源基因利用多角体启动子进行转录表达,并
分泌到细胞外,从而在细胞上清获得重组目的蛋白。家蚕表达系统(silkworm
baculovirus expression vector system, BEVS)表达的目的蛋白能够进行正确的
加工、修饰,使目的蛋白更接近于天然蛋白。同时家蚕细胞能识别哺乳动物的分泌
蛋白的信号肽序列。4B 基因克隆到家蚕杆状病毒转移载体 pVL1393 中,通过与家蚕
杆状病毒(Bombyx mori nuclear polyhedrosis virus, BmNPV)在家蚕 Bm 细胞中共
转染,重组到 BmNPV 中,通过筛选纯化,获得重组病毒。重组病毒感染家蚕细胞和 5
龄家蚕,表达 4B 蛋白,分子量约为 16 kDa, 与预测的大小相吻合。并用 Western blot
鉴定该重组蛋白能识别猪囊虫病人(猪)阳性血清。4B 基因在家蚕细胞中的表达对
进一步研究 45W 基因的结构功能,并开发出更可行、方便的基因工程疫苗打下基础。
45W gene family of Taenia solium constitutes of a group of genes that have familiar
structure and function. Three types of 45W genes of T. solium, A type, B type and C type
were produced through alternative splicing. A transcript is composed of the four exons
Ⅰ, Ⅱ, Ⅲ and Ⅳ, B transcript is lack of exon Ⅱ, and C transcript is lack of exons Ⅱ
and Ⅲ. The same exon between different genes is highly homologous, but shows some
variations.
45W genes of T. solium were identified to be a talent candidate gene for gene
recombinant vaccine. In this study, 4B full-length and 3′truncated gene were successfully
cloned into pET-28a vector, and expressed in BL21. The products of expression were
detected by Western blot with serum of human infected with Cysticercus Cellulosae, and
showed its antigenicity.
The form of alternative splicing of 45W gene family interested many parasitologists.
In these transcripts, 4B gene is a special one with the most variation contrast with the
other genes of 45W. In this study, 4B protein was isolated and used to vaccinate
intraperitoneally the Kunming line mice for twice, then the anti-serum of the mice was
pooled for the following Western blot with the tissue protein of Cysticercus cellulosae.
The Western blot appears the band in the 50 kDa, which shows that 4B protein fused with
6 HIS have antigenicity, and can stimulate mice to produce antigen-specific antibody. On
the other hand, it can be ascertained that 4B protein is presented in the tissue of
cysticercus cellulosae with the polymer. 4B gene and protein sequence is analyzed using
the DNAstar software, and blasted using Protein Data base (PDB), showed that 4B protein
have potential antigenicity, and in this protein there is a Fibronectin (FN) domain. It is
predicted that the 45W protein is related to forming of cysticercus.
Expression system of BmNPV-Bm is high effective for producing recombinant
protein approach to its nature structure by the correct post-transcript process and
modification. 45W-4B gene of T. solium was cloned into baculovirus transfer vector of
pVL1393 and cotransfected into Bombyx mori nuclear polyhedrosis virus (BmNPV). The
recombinant BmNPV was screened, and used to infect Bm-N cells and silkworm. 4B
protein was detected in the cell supernatant and haemolyph by Western blot using serum
of human (and swine) infected with Cysticercus Cellulosae. Successful expression of 4B
recombinant protein in BmNPV-Bm will be significant for study the structure and function
of 4B protein, and development of the effective recombinant vaccine against T. solium and
Cysticercus Cellulosae.
引文
[1] 孔繁谣. 家畜寄生虫学[M]. 第 2 版, 中国农业大学出版社, 1997.
[2] 詹希美. 人体寄生虫学[M]. 第 5 版, 北京:人民卫生出版社,2001.
[3] 顾有方, 沈永林. 猪囊虫病免疫诊断技术的研究进展[J]. 中国兽医寄生虫病,
1998, 6(2):41-44.
[4] 阎宝坤, 郭文银, 牛宗力, 等. 炭末抗原凝集反应诊断猪囊尾蚴病效果[J]. 兽
医科技杂志, 1984, 12:44-45.
[5] 蒋连祥, 施正良, 翟春生. 应用猪囊虫匀浆抗原间接血凝试验检测猪囊虫病抗
原的研究[J]. 兽医大学学报, 1988, 8(3):234-236.
[6] 王佩雅, 景志忠, 才学鹏,等. 应用干血纸 ELISA 诊断猪囊虫病的研究[J]. 中
国兽医科技, 2000, 11:18-19.
[7] 裘丽珠,周慧娟. 几种猪囊尾蚴抗原用于 EITB 法诊断猪囊尾蚴病的观察[J]. 中
国血吸虫病防治杂志,1998,10(1):19-32.
[8] 李莹, 应慧丽, 等. 猪囊尾蚴病快速诊断方法的试验研究[J]. 中国热带医学,
2002,2(1):16-18.
[9] 朱炎鹏, 田广孚, 陈玉珍, 等. 猪囊虫生前诊断方法的研究—间接血球凝集反
应诊断猪囊虫病的初步试验[A]. 全国家畜寄生虫科研工作第二次会议论文摘要
集[C], 1980,192.
[10] 柴忠威, 才学鹏, 邓国华, 等. 猪囊尾蚴 B 抗原的克隆及鉴定[J]. 中国预防兽
医学报, 1999, 21(4):308-310.
[11] 孙树汉, 王俊霞, 陈蕊雯, 等. 囊虫病诊断用抗原编码cDNA的分子克隆[J]. 中
国寄生虫学与寄生虫病杂志, 1997, 15:15-20.
[12] 朱森林, 陈旻湖, 陈洁, 等. 减毒鼠伤寒沙门氏菌全长 hpaA 基因工程菌的构建
[J]. 微生物学报, 2002, 42(1):27-32.
[13] 赵平, 王宏卫, 卢洋, 等. 携带HBV胞膜大蛋白DNA疫苗的减毒沙门氏菌在小鼠
诱导免疫应答[J]. 生物工程学报, 2002, 18:601-604.
[14] 董家新,沈倍奋,任蕴芳,等. 人白结素 6 受体基因在痘病毒载体系统中的表达
[J]. 中国生物化学与与分子生物学报, 1995, 4:386-391.
[15] 苛克勉, 安晓荣, 田见晖, 等. 动物乳腺生物反应器的现状和趋势[J]. 生物工
程学报, 2002, 18:144-148.
[16] 陈瑞环. 转基因动物的乳腺表达. 生物化学与生物物理进展[J]. 1994,
21:42-47.
[17] 奥斯伯 F. 精编分子生物学试验指南[M], 科学出版社, 1998.
52
参考文献·53·
[18] 吕鸿声. 中国养蚕学[M].上海:科技出版社, 1991.
[19] 萨姆布鲁克 JEF, 弗里奇 T, 曼尼阿蒂斯. 分子克隆实验指南[M]. 第 2 版, 北
京:科学出版社. 1992.
[20] 贾万忠. 带绦虫 45W 基因及 14 kDa 和 18 kDa 基因的变异分析[D]. 兰州:中国
农业科学院,博士论文,2003.
[21] 张中庸, 李靓如. 细胞工程抗寄生虫的研究[J]. 天津农学院学报, 2001,
8:6-9.
[22] 储瑞银, 宓怡德, 吕鸿声, 等. 乙型肝炎病毒 表面抗原基因(preS2-S)在家蚕
培养细胞中的表达[J]. 生物化学与生物物理学报,1990,22:385-390.
[23] 刘金明, 蔡学忠, 林娇娇, 等. 日本血吸虫脂肪酸结合蛋白在家蚕细胞及幼虫
中的表达[J]. 中国寄生虫学与寄生虫病杂志, 1999, 17:218-221.
[24] 王文兵,姚斌,肖庆利,等. 植酸梅基因在家蚕杆状病毒表达载体中的表达 及
其酶学特性. 生物工程学报,2003,1:112-115.
[25] 李卫党,何家禄,许化溪,等. 家蚕记忆工程表达系统的安全性研究. 中国人兽
共患病杂志,1999,6:40-43.
[26] Hoberg EP. Taenia tapeworms: their biology, evolution and socioeconomic
significance[J]. Microbes Infect, 2002, 4(8):859-866.
[27] Runrungroj W, Charoenhirunyingyos S, Wanachiwanawin O, et al.
Neucysticercosis: Clinical manifestions and assessments[J], Siriraj
Hospital Gazette, 2002, 54(7):394-402.
[28] Martinez-Maya JJ, de Aluja AS, Avila-Ramirez G, et al. Taeniasis and
detection of antibodies against cysticercus among inhabitants of a rural
community in Guerrero State. Mexico[J]. Salud Publica Mex, 2003,
45(2):84-89.
[29] Fleury A, Gomez T, Alvarez I, et al. High prevalence of calcified silent
neurocysticercosis in a rural village of Mexico[J]. Neuroepidemiol, 2003,
22(2):139-145.
[30] Margono SS, Ito A, Sato MO, et al. Taenia solim Taeniasis/cysticercosis
in Pupua, Indonesia in 2001:detection of human worm carries. J Helminthol,
2003, 77(1):39-42.
[31] Houinato D, Ramanankandrasana B, Adjide C, et al. Seroprevalent of
cysticercosis in Benin[J]. Trans R Soc Trop Med Hyg, 1998, 92(6):621-624.
[32] Daugherty JW. Intermediary protein metabolism in helminths. IV. The active
absorption of methionine by the cestode, H. diminuta[J]. Exp Parasitol,
1957, 6(1):60-67.
53
·54· 猪带绦虫 45W-4B 基因在大肠杆菌和家蚕中的表达及 45W 蛋白结构和功能的初步研究
[33] Pappas PW, Uglem GL, Read CP. Anion and cation requirements for glucose
and methionine accumulation by Hymenolepis diminuta (Cestoda) [J]. Biol
Bull, 1974, 146(1):56-66.
[34] Papaas PW, Uglem GL, Read CP. Taenia Crassiceps: Absorption of Hexose and
partial characterization of Na+-dependent glulose absorption by larvae[J].
Exp Parasitol, 1973, 33:127-137.
[35] Gauci CG, Lightowlers MW. Alternative splicing and sequence diversity of
transcripts from the oncosphere stage of Taenia solium with homology to
the 45W antigen of Taenia ovis[J]. Mol Biochem Parasitol, 2001,
112(2):173-181.
[36] Brehm K, Hubert K, Scitto E, et al. Characterization of a spliced gene
and of trans-spliced mRNAs from Taenia solium[J]. Mol Biochem Parasitol,
2002, 122:105-110.
[37] Cnotreras DR, Skelly PJ, Landa A, et al. Molecular and function
characterization and tissue localization of 2 glucose tansporter
homologues (TGTP1 and TGTP2) from the tapeworm Taenia solium[J]. Parasitol,
1998, 117:579-588.
[38] Von Brand T, Mcmahon P, Cibbs E, et al. Aeroic and anaerobic metabolism
of larval and adult taenia taeniaeformis.Ⅱ. Hexose leakageand absorpion;
tissue glucose and polysaccharides[J]. Exp Parasitol, 1964, 15:410-429
[39] Pappas PW, Read CP. Memberane transport in the helmith parasite: A
review[J], Exp Parasitol, 1975, 37:469-530.
[40] Gasser RB, Zhu X, Mcmanus DP. NADH dehydrogenase subunit I and cytochrome
coxdase subunit I sequences compared for members of genus
Taenia(cestoda)[J]. Int J Parasitol, 1999, 29:1965-1970.
[41] Hancock K, Broughel DE, and Moura INS. Sequence variation in
thecy-tochrome oxidaseⅠ, intertranscribed spacer Ⅰ, and Ts14 in
diagnostic an-tigen sequences of Taenia solium isolates from South and
Central America, India, and Asia[J]. Int J Parasitol, 2001,
31(41):1601-1607
[42] Gasser RB, Zhu X, Woods W. Genotyping Taenia tapeworms by single-strand
conformation polymorphism of mitochondrial DNA[J]. Electrophoresis, 1999,
20:2834-2837.
[43] Alger C, Veronica V, Kevin GM, et al. Isolation and characterization of
species-spccific DNA probes form Taenia solium and Taenia saginata and
54
参考文献·55·
their use in egg detection assay[J]. J Clin Microbiol, 1995, 33(5):
1283-1288.
[44] Pathak KM, Gaur SNS, Garg SK. Counter current immunoelectrophoresis, a
new technique for the rapid serodiagnosis of porcine cysticercosis[J].
J Helmithol, 1984. 58(4):321-324.
[45] Molinari JL, Meza R, Suarez B, et al. Taenia solium: immunity in the hogs
to the cysticercus[J]. Exp Parasitol, 1983, 55:340-357.
[46] Nascimento E, Costa JO, Guimaraca MP, et al. Effective immune protection
of pigs against cysticercosis[J]. Vet Immunol Immunoparasitol, 1995, 45:
127-137.
[47] Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot
assay and glycoprotein antigens for diagnosing human cysticercosis
(Taenia solium)[J]. J Infect Dis, 1989,159(1):50-59.
[48] Restrepo BI, Obregon-Henao A, Mesa M, et al. Characterisation of the
carbohydrate components of Taenia solium metacestode glycoprotein
antigens[J]. Int J Parasitol, 2000, 30(6):689-96.
[49] Larralde C, Sotelo J, Montoya RM, et al. Antigens from murine Taenia
crassiceps cysticerci effectively substitute those from porcine Taenia
solium[J]. Arch Pathol Lab Med, 1990, 114(9):926-928.
[50] Filsser A, Lightowers MW. Vaccine against Taenia solium Cysticercus[J].
Mem Inst Oswaldo Cruz, Rio de Janeiro, 2001, 96:353-356.
[51] Lackette JP, Landa A, Arcos L. Paramyosin is the Schistosoma mansoni
(Trematoda) homologue of antigen B form Taenia solium(Cestoda)[J]. Mol
Biochem Parasitol, 1991, 44:287-296.
[52] Johnson KS, Harrison GB, Lightowlers MW, et al. Vaccintion against ovine
cysticercusis using a defined recombination antigen[J]. Nature, 1989,
338:585-587.
[53] Chung JY, Bahk YY, Hub S, et al. A combinant 10 kDa protei of Taenia solium
metacestodes specific to active neucysticercosis[J]. J Infect Dis, 1999,
180:1307-1315.
[54] Greene RM, Wilkines PP, Tsang VCM. Diagnostic glycoproteins of T. solium
cysts share homologous 14- and 18-kDa related, diagnostic antigen[J]. J
Parasitol, 2000, 86:1001-1007.
[55] Streatfield SJ, Howard JA. Plant-based vaccines[J]. Int J Parasitol, 2003,
33(5-6):479-493.
55
·56· 猪带绦虫 45W-4B 基因在大肠杆菌和家蚕中的表达及 45W 蛋白结构和功能的初步研究
[56] Kapusta J, Modelska A, Figlerowicz M, et al. A plant-drived edible vaccine
against hepatitis B virus. FASEB J, 1999,13:2339-2342.
[57] Wigdorovitz A,carrillo C, DusSantos M, et al. Induction of a protective
antibody response to foot and mouth disease virus in mice following oral
or parenteral immunization with alfalfa trandgenic plants expressing the
viral structural protein VP1, 1991, Virology 255:347-353.
[58] Wigdorovitz A, Perez F, Roberson N, et al. Protection of mice against
challenge with foot and mouth disease viruse (FMDV) by immuzation with
foliar extracts of plants infected with recombinant tobacoo mosaic virus
expressing the FMDV strustural protein VP1. 1991, Virology,264:86-89.
[59] Warzecha H, Mason HS. Benefits and risks of antibody and vaccine production
in transgenic plants[J]. J Plant Physiol, 2003, 160(7):755-64.
[60] Modelska A, Dietzschold B, Sleysh N, et al. Immunisation against rabies
with plant-derived antigen[J]. Proc Natl Acad Sci USA, 1998, 95:2481-2485.
[61] Mason HS, Ball JM, Shi JJ, et al. Expression of Norwalk virus capsid protein
in transgenic tobacco and potato and its oral immunogenicity in mice[J].
Pro Natl Acad Sci USA, 1996, 93:5335-5340.
[62] Brenman FR, Bellaby T, Helliwell Sm, et al. Chimeric plant virus particles
administered nasally or orally induced systemic and mucosal immune
responses in mice[J]. J Virol, 1999, 73:930-938.
[63] Huang Z, Dry IB, Webster DE, et al. Plant-derived measles virus
hemagglutinin protein induces neutralizing antibodies in mice[J]. Vaccine,
2001, 19:2163-2171.
[64] Wigdorovitz A, Carrilo C, Sadir AM, et al. Induction of a protective
antibody response to foot and mouth disease virus in mice following oral
or parenteral structural protein VP1[J]. Virology, 1999, 255:347-353.
[65] Ramshaw IA, Ramsay AJ. The prime-boost strategy: exciting prospects for
improved vaccination[J]. Immunol Today, 2000, 21: 163-165.
[66] Webster DE, Thomas MC, Strugnell RA, et al. Appetising solutions: an
edible vaccine for measles[J]. MJA, 2002, 167:434-437.
[67] Tanaka Y, Heminway B, Galinski M. Down-regulation of paramyxovirus
hemagglutinin-neuraminidase glycoprotein surface expressiong by a mutant
fusion protein containing a retention signal for the endoplasmic
reticulum[J]. J Virol, 1996, 70:5005-5015.
[68] Dniell H, Khan M, Allison L. Milestones in chloroplast genetic engineering:
56
参考文献·57·
an environmently friendly era in biotechnology[J]. Trends Plant Sci, 2002,
7:84-91.
[69] Strobel S, Mowat A . Immune responses to dietary antigens:oral tolerance[J].
Immuno Today, 1999, 19:173-181.
[70] Tsuji NM, mizumachi K, Kurisaki J. Interleukin-10-secreting Peyer’s
patch cells are responsible for active suppression in low-dose oral
tolerance[J]. Immunol, 2001, 103:458-464.
[71] Yancey RJ, Breeding SA, Lankford CE. Enterochelin (enterobactin):
virulence factor for Salmonella typhimurium[J]. Infect Immun, 1979,
24:174-80.
[72] Hoiseth SK, Stocker BAD. Aromatic-dependent Salmonella typhimurium are
non-virulent and effective as live vaccines[J]. Nature, 1981,
291:238-239.
[73] Pasetti MF, Levine MM, Sztein MB. Animal models paving the way for clinical
trial of attenuated Salmonella enterica serovar Typhi live oral vaccines
and live vectors[J], Vaccine, 2003, 21:401-18.
[74] Vazquez-Torres A, Jones-Carson J, Baumler AJ et al. Extraintestinal
dissemination of Salmonella by CD18-expressing phagocytes[J]. Nature,
1990,401:804-808.
[75] Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight
junction proteins and penetrate gut epithelial monolayers to sample
bacteria[J]. Nat immunol, 2001, 2:361-7.
[76] Helen S, Garmory, Kate F, et al. Oral immunisation with live aroA
attenuated Salmonella enterica serovar Typhimurium expressing the
Yersinia pestis V antigen protects mice against plague[J]. Vaccine, 2003,
21: 3051-3057.
[77] Patrick CY. Woo, Lei-po Wong, Bo-jian Zheng, et al. Unique immunogenicity
of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella
typhimurium[J]. Vaccine, 2001, 19:2945-2954.
[78] Corthesy-theulaz IE, Hopkins S, Bachmann D, et al. Mice are protected from
Helicobacter pylori infection by nasal immunization with attenuated
Salmonella typhimurium phoPc expressing urease A and B subunits[J]. Infect
Immun, 1998, 66(2):581-586.
[79] Staats HF, Jackson RJ, Marinaro M, et al. Mucosal Immunity to infection
with implication for vaccine development[J]. Curr opin Immunol, 1994,
57
·58· 猪带绦虫 45W-4B 基因在大肠杆菌和家蚕中的表达及 45W 蛋白结构和功能的初步研究
6:572-583.
[80] Soboll G, Nelson KM, Leuthner ES, et al. Mucosal co-administration of
cholera toxin and influenza virus hemagglutinin-DNA in ponies generates
a local IgA response[J], Vaccine, 2003, 21:3081-3092.
[81] Drabner B, Guzman CA. Elicitation of predictable immune responses by using
live bacterial vectors[J]. Biomol Eng, 2001, 17(3):75-82.
[82] Albert ML, Sauter, Bhardwaj N. Dendritic cells acquire antigen from
apoptotic cell and induce Ⅰ-restricted CTLs[J]. Nature, 1998, 392:86-9.
[83] Cardenas L, Clements JD. Oral immunization using live attenuated Salmonell
spp. As carriers of foreign antigens[J]. Clin Microbiol Rev, 1992, 5(3):
328-342.
[84] Chen JP, Lin C, Xu CP, et al. The therapeutic effects of recombinant
adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo.
World J Gastroenterol, 2000, 6:855-860.
[85] Pan X, Li Z, Zhang M, Wang Y, et al. Therapeutic effect of
endostatin-vascular endothelial growth inhibitor recombinant
adenoviruses on gaastric carinoma nude mice. Shijie Huaren Xiaohua Zazhi.
2003,11:1282-1285
[86] Li XL, Peng YZ, Yuan ZQ, et al. Preparation of human HSP72 cDNA recombinant
adenovirus and its expression in IEC-6 cell. Shijie Huaren Xiaohua Zazhi.
2002,10:1162-1165.
[87] Xu F, Hong M, Ulmer JB. Immunogenicity of an HIV-1 gag DNA vaccine carried
by attenuated Shigella. Vaccine, 2003, 30:644-648.
[88] Yu XP, Zhu JL, Yao XP, et al. Contruction and verification of the
effectiveness of pMBL: a cloing of exported proteins encoding genes. Yi
Chuan Xue Bao. 2003,30:730-736.
[89] Ebert KM,Selgrath JP, Ditullio P, et al. Transgenic production of a viriant
of human tissue-type and analysis of expression. Bio/Tech,1991,9:835-838.
[90] Wright G, Carver A, Cottom D, et al. High level expression of active human
alpha-1-antitrypsin in the milk of transgenic sheep.
Bio/Tech,1991,9:830-834.
[91] Krimpenfort P, Rademakers A,Eystone W, et al. Generation of transgenic
dairy cattle using “in vitro: embryo production. Bio/Tech,
1991,9:844-847
[92] Drohan WN. The past, present and future of transgenic bioreactors[J].
58
参考文献·59·
Thromb Haemost, 1997, 78(1):543-547.
[93] Hyttinen JM, Korhonen VP, Hiltunen MO, et al. High-level expression of
bovine beta-lactoglobulin gene in transgenic mice[J]. J Biotechnol, 1998,
61:191-198.
[94] Summers MD, Smith GE. A manual of methods for baculovirus vectors and
insect cell culture procedures[M]. Texas Agriculture Expriment Sation
Bulletin, 1987, No.1555.
[95] Lightowlers MW, Waterkeyn JG, Gauci CG, et al. Host-protective fragments
and antibody binding epitopes of Taenia ovis 45W recombinant antigen[J].
Parasite Immunology, 1996, 18:507-13.
[96] Rothel JS, Lightowers MW, and Seow HF. Immune responses associated with
protection in sheep vaccinated with recombinant antigen from Taenia
ovis[J]. Parasite Immunology, 1996, 18:201-208.
[97] Warterkeyn JG, Gauci CG, Cowman A, et al. Sequence analysis of a genefamily
encoding Taenia ovis vaccine antigen expressed during embryogenesis of
eggs[J]. Mol Biochem Parasitol, 1997, 86:75-84.
[98] Gao M, Craig D, Lequin O, et al. Structure and functional significance
of mechanically unfolded fibronectin type III intermediates[J]. Proc Natl
Acad Sci USA, 2003, 100(25):14784-14789.
[99] Liu X, Zhao Q, Collodi P. A truncated form of fibronectin is expressed
in fish and mammals[J]. Matrix Biol, 2003, 22(5):393-6.
[100] Yu ZF, Yu SK, Cai XP, et al. Expression of 45W-4B full-length and
truncated gene of Taenia solium in E.coli[A]. Animal biotechnology
bulletin[C], 2004
[101] Miyajima A, Schreurs J, Otsu K, et al. Use of the silkworm, Bombyx mori
and an insect baculovirus for high-level expression and secretion of
biologically active mouse interleukin-3[J]. Gene, 1987, 58:273-281.
[102] Maeda S, Kawai T, Obinata M, et al. Production of human-interferon in
silkworm using a baculoirus vector[J]. Nature, 1985, 315:593-596.
[103] Marumoto Y, Sato Y, Fuhiwara H, et al. Hyperproduction of
ployhedrin-IGF- Ⅱ fusing protein in silkworm larvae infected with
recombinant Bombyx mori nuclear polyhedrosis virus[J]. J Gen Virol, 1987,
68:2599-2606.
59